T. V. Legalova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
T. V. Legalova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- E. A. Mateykovich
Tyumen State Medical University; Perinatal Medical Center
3 shared publications - A M Suldin
The Federal State Budget Educational Institution of Higher Education "The Tyumen State Medical University", 625023, Tyumen, Russia,
1 shared publication A. S. Shvechkova
Tyumen State Medical University
1 shared publication- A.V. Prilenskaya
ФГБОУ ВО Тюменский ГМУ Минздрава России, Тюмень, Россия
1 shared publication - Andrei E. Bautin
Almazov National Medical Research Center
1 shared publication E. A. Yakovleva
Perinatal Center
1 shared publication
Latest Publications
- Open Access
- 24 September 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (3) , 216-222
Various aspects of connective tissue dysplasia in the context of obstetric and gynecological practice. To know so as not to lose. A review
Currently, the problem of connective tissue dysplasia (CTD) remains a significant concern. Its manifestations are highly variable, including in obstetric and gynecological practice. Therefore, it is necessary to address complications of pregnancy associated with CTD. We reviewed key papers, primarily published between 2018 and 2024, on CTD in obstetric and gynecological practice by authors from Russia and the CIS countries, given the virtual absence of scientific publications on this topic in the foreign literature. These data confirm the presence of such a pathology as CTD in women of reproductive age, which can become a trigger for a complicated course of pregnancy. The issues of diagnosis, prevention, and treatment of this disorder remain relevant; therefore, further research is necessary in this area to develop algorithms for the prevention and management of patients with CTD.
- 24 September 2025
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 27 (3) , 216-222
Open AccessVarious aspects of connective tissue dysplasia in the context of obstetric and gynecological practice. To know so as not to lose. A review
Currently, the problem of connective tissue dysplasia (CTD) remains a significant concern. Its manifestations are highly variable, including in obstetric and gynecological practice. Therefore, it is necessary to address complications of pregnancy associated with CTD. We reviewed key papers, primarily published between 2018 and 2024, on CTD in obstetric and gynecological practice by authors from Russia and the CIS countries, given the virtual absence of scientific publications on this topic in the foreign literature. These data confirm the presence of such a pathology as CTD in women of reproductive age, which can become a trigger for a complicated course of pregnancy. The issues of diagnosis, prevention, and treatment of this disorder remain relevant; therefore, further research is necessary in this area to develop algorithms for the prevention and management of patients with CTD.
- 8 December 2024
- Published by LLC M-Center in Суицидология
- Vol. 15 (03(56)) , 136-158
Suicidal contingent in the overall structure of poisoning in Russia
Individuals who commit deliberate self-poisoning for suicidal reasons make up at least a quarter of the contingent of toxicology centers in Russia, which indicates the scale of the problem. The suicidal contingent differs from unintentional victims in a number of key indicators. Women predominate among those who commit suicide (up to 73%), with the mean age of 32.5 years. There is a high proportion of unmarried – 31-45%, divorced – 6.3% people, a significant proportion are unemployed (39.5%). Upon admission to hospital, 70.2% are diagnosed with neurotic and stress-related disorders (F40-F48). Often, victims are examined by a psychiatrist or clinical psychologist not on the first day, when the most complete picture is needed to make a correct diagnosis. It is assumed that many are not diagnosed with depression. Alcohol is detected in a third of suicide attempters. The motives are predominantly interpersonal conflicts, less often they report the loss of a loved one, somatic disease, in isolated cases productive psychopathological symptoms can be found. Often the motives cannot be established. In 80-87% of attempts, medication is used. Psychotropic drugs (21.6-55.4%), cardiotropic drugs (22.5%), analgesics and antispasmodics (up to 12.5%) predominate. At least a third of suicide victims (36%) use combined medication, which usually entails increased toxic effects. For a number of territories of the country, the use of acids and alkalis (mainly acetic acid) remains relevant – up to 6-7%, poisoning with which determines high mortality. Intentional poisonings with inhalants (carbon monoxide, helium, etc.) are isolated cases. Mortality is on average 1.7-3.1%. The diagnosis of poisoning, especially committed for suicidal reasons, is not always obvious and simple. At the time of the initial examination, 61.5% of patients do not have pronounced clinical manifestations of acute poisoning. Often, victims deny what they did, which requires a more thorough questioning, examination, involvement of other people and objective data. Therefore, when making a diagnosis, it is recommended to use the principle of the "toxicological diagnostic triad": 1) the presence of a toxicological anamnesis; 2) toxicological situation and 3) a characteristic clinical picture, in combination with the fourth (4) task – identifying suicidal history and motives. Conclusion. In order to reduce the number of poisonings for suicidal reasons, a comprehensive system of measures is needed with broader involvement of mental health specialists, social workers, teachers, improvement of the work of the media and Internet resources. Among the key tasks are training and broader educational work on preventive suicidology among medical personnel, psychologists, social workers, volunteers providing assistance in cases of deliberate self-poisoning, the formation of a multi-level system of suicidological alertness for the purpose of earlier identification of this category of people, providing them with assistance and preventing tragic consequences. Keywords: suicidal poisoning, deliberate poisoning, poisoning for suicidal reasons, drug poisoning, suicide attempt, diagnosis of suicidal poisoning, poisoning prevention, suicide prevention
- 8 December 2024
- Published by LLC M-Center in Суицидология
- Vol. 15 (03(56)) , 136-158
Suicidal contingent in the overall structure of poisoning in Russia
Individuals who commit deliberate self-poisoning for suicidal reasons make up at least a quarter of the contingent of toxicology centers in Russia, which indicates the scale of the problem. The suicidal contingent differs from unintentional victims in a number of key indicators. Women predominate among those who commit suicide (up to 73%), with the mean age of 32.5 years. There is a high proportion of unmarried – 31-45%, divorced – 6.3% people, a significant proportion are unemployed (39.5%). Upon admission to hospital, 70.2% are diagnosed with neurotic and stress-related disorders (F40-F48). Often, victims are examined by a psychiatrist or clinical psychologist not on the first day, when the most complete picture is needed to make a correct diagnosis. It is assumed that many are not diagnosed with depression. Alcohol is detected in a third of suicide attempters. The motives are predominantly interpersonal conflicts, less often they report the loss of a loved one, somatic disease, in isolated cases productive psychopathological symptoms can be found. Often the motives cannot be established. In 80-87% of attempts, medication is used. Psychotropic drugs (21.6-55.4%), cardiotropic drugs (22.5%), analgesics and antispasmodics (up to 12.5%) predominate. At least a third of suicide victims (36%) use combined medication, which usually entails increased toxic effects. For a number of territories of the country, the use of acids and alkalis (mainly acetic acid) remains relevant – up to 6-7%, poisoning with which determines high mortality. Intentional poisonings with inhalants (carbon monoxide, helium, etc.) are isolated cases. Mortality is on average 1.7-3.1%. The diagnosis of poisoning, especially committed for suicidal reasons, is not always obvious and simple. At the time of the initial examination, 61.5% of patients do not have pronounced clinical manifestations of acute poisoning. Often, victims deny what they did, which requires a more thorough questioning, examination, involvement of other people and objective data. Therefore, when making a diagnosis, it is recommended to use the principle of the "toxicological diagnostic triad": 1) the presence of a toxicological anamnesis; 2) toxicological situation and 3) a characteristic clinical picture, in combination with the fourth (4) task – identifying suicidal history and motives. Conclusion. In order to reduce the number of poisonings for suicidal reasons, a comprehensive system of measures is needed with broader involvement of mental health specialists, social workers, teachers, improvement of the work of the media and Internet resources. Among the key tasks are training and broader educational work on preventive suicidology among medical personnel, psychologists, social workers, volunteers providing assistance in cases of deliberate self-poisoning, the formation of a multi-level system of suicidological alertness for the purpose of earlier identification of this category of people, providing them with assistance and preventing tragic consequences. Keywords: suicidal poisoning, deliberate poisoning, poisoning for suicidal reasons, drug poisoning, suicide attempt, diagnosis of suicidal poisoning, poisoning prevention, suicide prevention
- 21 November 2024
- Published by LLC M-Center in Академический журнал Западной Сибири
- Vol. 20 (03(104))
Ведение беременности и родов у больных эпилепсией
- 21 November 2024
- Published by LLC M-Center in Академический журнал Западной Сибири
- Vol. 20 (03(104))
Ведение беременности и родов у больных эпилепсией
- Open Access
- 6 April 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 66-73
Surfactant therapy for pneumonia COVID-19 of obstetric patients
Introduction. Pregnant women may be at increased risk for severe COVID-19 illness. Pregnant women are more likely to be hospitalized at ICU, needed the mechanical ventilation compared to nonpregnant women of childbearing age. Building on the experience of the effective use of the exogenous surfactant for influenza A/H1N1 treatment of pregnant women with COVID-19, the surfactant therapy has also been included in the treatment.The objective. To evaluate the effectiveness of surfactant therapy in the integrated treatment of severe COVID-19 pneumonia of pregnant women and postpartum women.Materials and methods. The study included 135 pregnant and postpartum women with severe COVID-19 pneumonia. All of them received antiviral, anticoagulant, anticytokine and anti-inflammatory therapy. 68 patients (main group) with an initially more severe course of the disease and a greater degree of lung damage (p = 0.026) received inhalations with Surfactant-BL, 67 patients (control group) did not receive the surfactant therapy. Patients received Surfactant-BL through a mesh-nebulizer at a dose of 75 mg 2 times a day for 3–5 days.Result. Patients of the main group showed decreasing risks of requiring the noninvasive ventilation (27.9% vs. 52.2%, р = 0.014) and artificial lung ventilation (2.9% vs. 11.9%, p = 0.047), the length of stay in the intensive care unit (ICU) was reduced (10.6 vs. 13.1 inpatient days, р = 0.045). Сomplications such as pneumomediastinum and pneumothorax occurred less frequently in the surfactant therapy group (24.2% vs. 52.4%, p = 0.037) with a high extent of lung damage (CT-3–4). With early surfactant therapy in the standard oxygen therapy stage or high-flow oxygenation, gas exchange indicators were restored faster, thus avoiding mechanical ventilation and has reduced the duration of intensive care (р = 0.004) and prevented deaths.Conclusion. The use of surfactant therapy for pneumonia associated with COVID-19 in pregnant and postpartum women against the background of ongoing complex therapy helps to prevent further lung damage, reduce the mechanical ventilation risk and improve oxygenation earlier, especially with early start of surfactant therapy.
- 6 April 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 66-73
Open AccessSurfactant therapy for pneumonia COVID-19 of obstetric patients
Introduction. Pregnant women may be at increased risk for severe COVID-19 illness. Pregnant women are more likely to be hospitalized at ICU, needed the mechanical ventilation compared to nonpregnant women of childbearing age. Building on the experience of the effective use of the exogenous surfactant for influenza A/H1N1 treatment of pregnant women with COVID-19, the surfactant therapy has also been included in the treatment.The objective. To evaluate the effectiveness of surfactant therapy in the integrated treatment of severe COVID-19 pneumonia of pregnant women and postpartum women.Materials and methods. The study included 135 pregnant and postpartum women with severe COVID-19 pneumonia. All of them received antiviral, anticoagulant, anticytokine and anti-inflammatory therapy. 68 patients (main group) with an initially more severe course of the disease and a greater degree of lung damage (p = 0.026) received inhalations with Surfactant-BL, 67 patients (control group) did not receive the surfactant therapy. Patients received Surfactant-BL through a mesh-nebulizer at a dose of 75 mg 2 times a day for 3–5 days.Result. Patients of the main group showed decreasing risks of requiring the noninvasive ventilation (27.9% vs. 52.2%, р = 0.014) and artificial lung ventilation (2.9% vs. 11.9%, p = 0.047), the length of stay in the intensive care unit (ICU) was reduced (10.6 vs. 13.1 inpatient days, р = 0.045). Сomplications such as pneumomediastinum and pneumothorax occurred less frequently in the surfactant therapy group (24.2% vs. 52.4%, p = 0.037) with a high extent of lung damage (CT-3–4). With early surfactant therapy in the standard oxygen therapy stage or high-flow oxygenation, gas exchange indicators were restored faster, thus avoiding mechanical ventilation and has reduced the duration of intensive care (р = 0.004) and prevented deaths.Conclusion. The use of surfactant therapy for pneumonia associated with COVID-19 in pregnant and postpartum women against the background of ongoing complex therapy helps to prevent further lung damage, reduce the mechanical ventilation risk and improve oxygenation earlier, especially with early start of surfactant therapy.